We are live on ! Find out more
CT

Cambridge Trust Portfolio holdings

AUM $2.64B
1-Year Est. Return 28.73%
This Fund
S&P 500
This Quarter Est. Return
+3.33%
1 Year Est. Return
+28.73%
3 Year Est. Return
+42.93%
5 Year Est. Return
+123.28%
10 Year Est. Return
+319.24%
AUM
$1.42B
AUM Growth
+$53.3M
Cap. Flow
+$29.9M
Cap. Flow %
2.1%
Top 10 Hldgs %
26.02%
Holding
276
New
21
Increased
128
Reduced
73
Closed
13

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$6.96M
2
MRK icon
Merck
MRK
+$6.29M
3
UNH icon
UnitedHealth
UNH
+$5.85M
4
AMZN icon
Amazon
AMZN
+$5.11M
5
META icon
Meta Platforms (Facebook)
META
+$4.86M

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$11.9M
2
CAH icon
Cardinal Health
CAH
+$9.07M
3
T icon
AT&T
T
+$3.98M
4
MDT icon
Medtronic
MDT
+$3.36M
5
EL icon
Estee Lauder
EL
+$2.92M

Sector Composition

Rank Sector Weight
1 Financials 17.84%
2 Healthcare 14.41%
3 Technology 13.82%
4 Industrials 11.14%
5 Energy 9.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPC icon
51
Genuine Parts
GPC
$19B
$9.91M 0.7%
103,711
+38
+0% +$3.62K
BUD icon
52
AB InBev
BUD
$158B
$9.75M 0.69%
92,452
-783
-0.8% -$87.8K
KMB icon
53
Kimberly-Clark
KMB
$36.4B
$9.09M 0.64%
79,613
-873
-1% -$101K
HXL icon
54
Hexcel
HXL
$7.17B
$8.67M 0.61%
168,489
+1,735
+1% +$83.4K
VZ icon
55
Verizon
VZ
$208B
$7.94M 0.56%
148,731
+538
+0.4% +$26.9K
PEP icon
56
PepsiCo
PEP
$193B
$7.79M 0.55%
74,444
-637
-0.8% -$66.7K
BFH icon
57
Bread Financial
BFH
$4.06B
$7.74M 0.55%
42,443
-2,634
-6% -$458K
ACN icon
58
Accenture
ACN
$116B
$7.63M 0.54%
65,157
+1,612
+3% +$191K
EV
59
DELISTED
Eaton Vance Corp.
EV
$6.83M 0.48%
163,194
+11,731
+8% +$461K
WSO icon
60
Watsco Inc
WSO
$12.8B
$6.83M 0.48%
46,109
+2,459
+6% +$356K
CBT icon
61
Cabot Corp
CBT
$4.32B
$6.82M 0.48%
134,998
WEC icon
62
WEC Energy
WEC
$34.6B
$6.34M 0.45%
108,134
+3,775
+4% +$217K
PFE icon
63
Pfizer
PFE
$159B
$6.03M 0.42%
195,528
-8,213
-4% -$251K
WTRG icon
64
Essential Utilities
WTRG
$11.7B
$5.75M 0.41%
191,574
+73,299
+62% +$2.19M
DIS icon
65
Walt Disney
DIS
$187B
$5.74M 0.4%
55,031
+52
+0.1% +$5.07K
T icon
66
AT&T
T
$178B
$5.64M 0.4%
175,614
-134,928
-43% -$3.98M
SPY icon
67
State Street SPDR S&P 500 ETF Trust
SPY
$825B
$5.29M 0.37%
23,647
+1,992
+9% +$435K
MCO icon
68
Moody's
MCO
$89.2B
$5.23M 0.37%
55,507
-1,683
-3% -$170K
JPM icon
69
JPMorgan Chase
JPM
$951B
$5.12M 0.36%
59,292
+3,579
+6% +$273K
CTRA
70
DELISTED
Coterra Energy
CTRA
$5.1M 0.36%
218,504
INTC icon
71
Intel
INTC
$473B
$5.04M 0.35%
138,935
+2,205
+2% +$79K
NVS icon
72
Novartis
NVS
$292B
$4.93M 0.35%
75,571
-182,900
-71% -$11.9M
SIX
73
DELISTED
Six Flags Entertainment Corp.
SIX
$4.89M 0.34%
81,538
+1,983
+2% +$111K
CLX icon
74
Clorox
CLX
$12.4B
$4.79M 0.34%
39,912
+252
+0.6% +$29.7K
NLSN
75
DELISTED
Nielsen Holdings plc
NLSN
$4.69M 0.33%
111,833
-28,938
-21% -$1.33M

Similar funds

Cambridge Trust's Q4 2016 Portfolio in Review

As of Q4 2016, Cambridge Trust held 276 positions worth $1.42B, up 3.9% from $1.37B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Cambridge Trust's Q4 2016 filing shows 21 new, 128 increased, 73 reduced and 13 closed positions. Its largest new stake was State Street Consumer Staples Select Sector SPDR ETF: 38,120 shares worth $1.97M. The largest sale was Novartis, an estimated $11.9M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.

  • Cambridge Trust's largest Q4 2016 buy was State Street Consumer Staples Select Sector SPDR ETF: 38,120 shares worth $1.97M.
  • Cambridge Trust added most to Celgene Corp in Q4 2016, an estimated $6.96M increase.
  • Cambridge Trust's biggest Q4 2016 reduction was Novartis, cutting an estimated $11.9M.
  • Cambridge Trust fully exited Cardinal Health in Q4 2016, selling an estimated $9.07M.
  • Cambridge Trust's ten largest holdings make up 26% of its $1.42B portfolio in Q4 2016.
  • Cambridge Trust opened 21 new positions and closed 13 in Q4 2016.
  • Cambridge Trust's portfolio value rose 3.9% quarter-over-quarter to $1.42B.

Based on Cambridge Trust's 13F filing for Q4 2016, filed 3 Feb 2017.